Peptide Stacks · Exact presentation
TB-500 + BPC-157 · 5 mg + 5 mg Stack
TB-500 + BPC-157 · 5 mg + 5 mg Stack describes separate products coordinated in one research reference. It does not represent a single-vial blend.
Educational research information for this exact variation. It is not medical advice, a prescription, or proof of regulatory approval.
TB-500 + BPC-157 Stack (5 mg Vials) Dosage Protocol
The source chart summarizes “1.25 mg” at “Weekly” frequency as educational information. PeptidosRD does not convert it into a clinical recommendation; any protocol must be checked against primary studies, applicable labeling, and qualified oversight.
Dosing & Reconstitution Guide
No reconstitution extrapolation is published because the unit, formulation, or composition does not support one reliable calculation from the source inventory. Reference concentration stated by the source: 2.5 mg/mL. It must be checked against the actual formulation and documentation.
TB-500 Protocol (2 mL Reconstitution = 2.5 mg/mL)
No reconstitution extrapolation is published because the unit, formulation, or composition does not support one reliable calculation from the source inventory. Reference concentration stated by the source: 2.5 mg/mL. It must be checked against the actual formulation and documentation.
TB-500 Protocol (2 mL Reconstitution = 2.5 mg/mL)
| Week | Dose (mcg) | Units (per injection) (mL) | Frequency |
|---|---|---|---|
| Weeks 1–4 | 1,250 mcg (1.25 mg) | 50 units (0.50 mL) | Twice weekly |
| Weeks 5–12 | 1,250 mcg (1.25 mg) | 50 units (0.50 mL) | Once weekly |
TB-500 Reconstitution Steps
No reconstitution extrapolation is published because the unit, formulation, or composition does not support one reliable calculation from the source inventory. Reference concentration stated by the source: 2.5 mg/mL. It must be checked against the actual formulation and documentation.
BPC-157 Protocol (2 mL Reconstitution = 2.5 mg/mL)
No reconstitution extrapolation is published because the unit, formulation, or composition does not support one reliable calculation from the source inventory. Reference concentration stated by the source: 2.5 mg/mL. It must be checked against the actual formulation and documentation.
BPC-157 Protocol (2 mL Reconstitution = 2.5 mg/mL)
| Week | Daily Dose (mcg) | Units (per injection) (mL) | Frequency |
|---|---|---|---|
| Weeks 1–2 | 250 mcg (0.25 mg) | 10 units (0.10 mL) | Once daily |
| Weeks 3–8 | 500 mcg (0.50 mg) | 20 units (0.20 mL) | Once daily |
| Weeks 9–12 | 250 mcg (0.25 mg) | 10 units (0.10 mL) | Once daily |
BPC-157 Reconstitution Steps
No reconstitution extrapolation is published because the unit, formulation, or composition does not support one reliable calculation from the source inventory. Reference concentration stated by the source: 2.5 mg/mL. It must be checked against the actual formulation and documentation.
Storage Instructions
Proper storage preserves peptide quality.
Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable for 1+ year.[5]
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 3–4 weeks and avoid freeze–thaw.[6]
Allow vials to reach room temperature before opening to reduce condensation uptake.
How This Works
The proposed mechanism depends on the molecular identity and receptor systems described in the literature. A mechanism alone does not establish clinical efficacy.
Potential Benefits & Side Effects
Identity, purity, sterility, stability, and equivalence to studied products cannot be assumed. Adverse effects and interactions may be incompletely characterized.
Source trail
Scientific references and source discovery
- PeptideDosages — exact TB-500 + BPC-157 · 5 mg + 5 mg Stack entrysecondary-structure
- PubMed — literature search for TB-500 + BPC-157primary-discovery
- ClinicalTrials.gov — study search for TB-500 + BPC-157trial-registry
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference